Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial.

Autor: Manji, Arif1 (AUTHOR) arif.manji@sickkids.ca, Samson, Yvan2 (AUTHOR) yvan.samson@umontreal.ca, Deyell, Rebecca J.3 (AUTHOR) rdeyell@cw.bc.ca, Johnston, Donna L.4 (AUTHOR) djohnston@cheo.on.ca, Lewis, Victor A.5 (AUTHOR) victor.lewis@albertahealthservices.ca, Zorzi, Alexandra P.6 (AUTHOR) alexandra.zorzi@lhsc.on.ca, Berman, Jason N.4 (AUTHOR) jberman@cheo.on.ca, Brodeur-Robb, Kathy7 (AUTHOR) kathy.brodeur-robb@c17.ca, Morrison, Ellen7 (AUTHOR) ellen.morrison@c17.ca, Kee, Lynn1 (AUTHOR) lynn.kee@sickkids.ca, Kumar, Sushil8 (AUTHOR) sushilkumar29@yahoo.ca, Baruchel, Sylvain1 (AUTHOR) sylvain.baruchel@sickkids.ca, Whitlock, James A.1 (AUTHOR) jim.whitlock@sickkids.ca, Morgenstern, Daniel A.1 (AUTHOR) daniel.morgenstern@sickkids.ca
Zdroj: Cancers. Jun2022, Vol. 14 Issue 12, p2985-N.PAG. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje